PriceTargets.com logo

Core Scientific - CORZ Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $18.75
  • Forecasted Upside: 71.70%
  • Number of Analysts: 17
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 16 Buy Ratings
  • 1 Strong Buy Ratings
$10.92 As of 05/20/2025 05:00 PM ET
▲ +0.07 (0.65%)

This chart shows the closing price for CORZ by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Core Scientific Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CORZ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CORZ

Analyst Price Target is $18.75
▲ +71.70% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Core Scientific in the last 3 months. The average price target is $18.75, with a high forecast of $25.50 and a low forecast of $14.50. The average price target represents a 71.70% upside from the last price of $10.92.

This chart shows the closing price for CORZ for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 17 investment analysts is to buy stock in Core Scientific. This rating has held steady since October 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/26/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/26/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/24/2024
  • 1 strong buy ratings
  • 13 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/22/2024
  • 1 strong buy ratings
  • 15 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/20/2025
  • 1 strong buy ratings
  • 15 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/21/2025
  • 1 strong buy ratings
  • 16 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/21/2025

Latest Recommendations

  • 1 strong buy ratings
  • 16 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/16/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$16.00 ➝ $16.00
5/14/2025OppenheimerInitiated CoverageOutperform$15.00
5/9/2025Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$17.00 ➝ $17.00
3/12/2025Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$17.00 ➝ $17.00
3/11/2025HC WainwrightReiterated RatingBuy ➝ Buy$17.00 ➝ $17.00
2/27/2025Cantor FitzgeraldLower TargetOverweight ➝ Overweight$24.00 ➝ $21.00
2/27/2025Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$17.00 ➝ $17.00
2/27/2025HC WainwrightReiterated RatingBuy ➝ Buy$17.00 ➝ $17.00
2/27/2025Needham & Company LLCLower TargetBuy ➝ Buy$18.00 ➝ $17.00
2/25/2025Compass PointLower TargetBuy ➝ Buy$26.00 ➝ $20.00
1/27/2025Keefe, Bruyette & WoodsInitiated CoverageOutperform$22.00
1/21/2025Craig HallumInitiated CoverageBuy$24.00
1/17/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
12/16/2024BTIG ResearchBoost TargetBuy ➝ Buy$19.00 ➝ $20.00
11/15/2024BTIG ResearchBoost TargetBuy ➝ Buy$15.00 ➝ $19.00
11/15/2024Roth MkmInitiated CoverageBuy$25.50
11/14/2024Roth CapitalUpgradeStrong-Buy
11/14/2024MacquarieBoost TargetOutperform ➝ Outperform$16.00 ➝ $19.00
11/7/2024B. RileyBoost TargetBuy ➝ Buy$16.00 ➝ $17.00
11/7/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$17.00 ➝ $17.00
11/7/2024Needham & Company LLCBoost TargetBuy ➝ Buy$17.00 ➝ $18.00
11/7/2024HC WainwrightBoost TargetBuy ➝ Buy$15.00 ➝ $17.00
10/28/2024Jefferies Financial GroupInitiated CoverageBuy$19.00
10/23/2024Compass PointBoost TargetBuy ➝ Buy$18.00 ➝ $20.00
10/23/2024Needham & Company LLCBoost TargetBuy ➝ Buy$16.00 ➝ $17.00
10/23/2024Canaccord Genuity GroupBoost TargetBuy ➝ Buy$16.00 ➝ $17.00
10/11/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$16.00 ➝ $16.00
10/11/2024B. RileyBoost TargetBuy ➝ Buy$13.00 ➝ $14.00
10/3/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$20.00 ➝ $20.00
9/25/2024MacquarieInitiated CoverageOutperform$16.00
9/23/2024Canaccord Genuity GroupInitiated CoverageBuy$16.00
9/23/2024Canaccord Genuity GroupInitiated CoverageBuy$16.00
9/10/2024Sanford C. BernsteinReiterated RatingOutperform ➝ Outperform$17.00 ➝ $17.00
9/4/2024Needham & Company LLCInitiated CoverageBuy$16.00
9/3/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$20.00 ➝ $20.00
8/8/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$20.00 ➝ $20.00
7/17/2024Cantor FitzgeraldInitiated CoverageOverweight$20.00
7/17/2024B. RileyUpgradeNeutral ➝ Buy$0.50 ➝ $13.00
7/10/2024HC WainwrightBoost TargetBuy ➝ Buy$11.00 ➝ $15.00
7/10/2024Sanford C. BernsteinInitiated CoverageOutperform$17.00
7/2/2024LADENBURG THALM/SH SHReiterated RatingBuy$14.50
6/26/2024BTIG ResearchBoost TargetBuy ➝ Buy$10.00 ➝ $15.00
6/25/2024HC WainwrightBoost TargetBuy ➝ Buy$5.00 ➝ $11.00
6/6/2024BTIG ResearchBoost TargetBuy ➝ Buy$8.00 ➝ $10.00
5/29/2024BTIG ResearchUpgradeNeutral ➝ Buy$8.00
3/13/2024HC WainwrightReiterated RatingBuy ➝ Buy$5.00
1/31/2024Compass PointUpgradeNeutral ➝ Buy$1.00 ➝ $8.50
1/25/2024HC WainwrightUpgradeNeutral ➝ Buy$5.00
11/3/2022DA DavidsonDowngradeBuy ➝ Neutral
11/1/2022Compass PointDowngradeBuy ➝ Neutral
10/28/2022B. RileyDowngradeBuy ➝ Neutral
10/28/2022HC WainwrightDowngradeBuy ➝ Neutral
10/28/2022BarclaysDowngradeOverweight ➝ Equal Weight
10/28/2022Chardan CapitalDowngradeBuy ➝ Neutral
10/27/2022BTIG ResearchDowngradeBuy ➝ Neutral
10/25/2022Compass PointLower TargetBuy$4.00 ➝ $2.25
10/24/2022DA DavidsonInitiated CoverageBuy ➝ Neutral
10/7/2022B. RileyLower TargetBuy$7.00 ➝ $5.00
10/4/2022BarclaysInitiated CoverageOverweight$3.00
9/27/2022Compass PointInitiated CoverageBuy$4.00
9/16/2022CowenLower TargetOutperform$4.00 ➝ $3.75
9/16/2022CowenLower TargetOutperform$4.00 ➝ $3.75
9/6/2022HC WainwrightInitiated CoverageBuy$5.00
8/15/2022DA DavidsonLower Target$9.00
8/15/2022CowenBoost Target$4.00
6/24/2022CowenInitiated CoverageOutperform$3.10
6/24/2022CowenInitiated CoverageOutperform$3.10
6/23/2022B. RileyLower TargetBuy$10.00 ➝ $7.00
6/3/2022Chardan CapitalInitiated CoverageBuy$8.00
6/3/2022BTIG ResearchLower TargetBuy$18.00 ➝ $8.00
5/31/2022LADENBURG THALM/SH SHLower TargetBuy$18.75 ➝ $15.00
3/17/2022B. RileyBoost Target$15.00 ➝ $16.00
2/24/2022BTIG ResearchInitiated CoverageBuy$18.00
2/11/2022B. RileyInitiated CoverageBuy$15.00
(Data available from 5/21/2020 forward)

News Sentiment Rating

1.41 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 16 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/23/2024
  • 11 very positive mentions
  • 24 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/22/2024
  • 27 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/22/2024
  • 12 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/21/2025
  • 24 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/20/2025
  • 25 very positive mentions
  • 30 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
3/22/2025
  • 40 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
4/21/2025
  • 57 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/21/2025

Current Sentiment

  • 57 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Core Scientific logo
Core Scientific, Inc. provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment. In addition, the company provides electrical power, repair, and other infrastructure services to operate, maintain, and earn digital assets; and sells mining equipment to customers. Core Scientific, Inc. was founded in 2017 and is headquartered in Dover, Delaware.
Read More

Today's Range

Now: $10.92
Low: $10.73
High: $11.22

50 Day Range

MA: $8.16
Low: $6.39
High: $10.85

52 Week Range

Now: $10.92
Low: $3.85
High: $18.63

Volume

12,404,707 shs

Average Volume

13,224,767 shs

Market Capitalization

$3.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

6.66

Frequently Asked Questions

What sell-side analysts currently cover shares of Core Scientific?

The following Wall Street sell-side analysts have issued research reports on Core Scientific in the last twelve months: B. Riley, BTIG Research, Canaccord Genuity Group Inc., Cantor Fitzgerald, Compass Point, Craig Hallum, HC Wainwright, Jefferies Financial Group Inc., Keefe, Bruyette & Woods, LADENBURG THALM/SH SH, Macquarie, Needham & Company LLC, Oppenheimer Holdings Inc., Roth Capital, Roth Mkm, and Sanford C. Bernstein.
View the latest analyst ratings for CORZ.

What is the current price target for Core Scientific?

0 Wall Street analysts have set twelve-month price targets for Core Scientific in the last year. Their average twelve-month price target is $18.75, suggesting a possible upside of 71.7%. Roth Mkm has the highest price target set, predicting CORZ will reach $25.50 in the next twelve months. LADENBURG THALM/SH SH has the lowest price target set, forecasting a price of $14.50 for Core Scientific in the next year.
View the latest price targets for CORZ.

What is the current consensus analyst rating for Core Scientific?

Core Scientific currently has 16 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CORZ will outperform the market and that investors should add to their positions of Core Scientific.
View the latest ratings for CORZ.

What other companies compete with Core Scientific?

Other companies that are similar to Core Scientific include Banco Santander-Chile, Ally Financial, Bancolombia, Woori Financial Group and Grupo Financiero Galicia. Learn More about companies similar to Core Scientific.

How do I contact Core Scientific's investor relations team?

Core Scientific's physical mailing address is 321 NORTH CLARK STREET SUITE 2440, CHICAGO IL, 60654. The company's listed phone number is 312-262-5642 and its investor relations email address is https://investors.corescientific.com. The official website for Core Scientific is www.xpdispac.com. Learn More about contacing Core Scientific investor relations.